D. Ossandón

680 total citations
19 papers, 102 citations indexed

About

D. Ossandón is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D. Ossandón has authored 19 papers receiving a total of 102 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Ophthalmology, 11 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D. Ossandón's work include Ocular Oncology and Treatments (9 papers), Retinopathy of Prematurity Studies (7 papers) and Neonatal Respiratory Health Research (5 papers). D. Ossandón is often cited by papers focused on Ocular Oncology and Treatments (9 papers), Retinopathy of Prematurity Studies (7 papers) and Neonatal Respiratory Health Research (5 papers). D. Ossandón collaborates with scholars based in Chile, United States and Argentina. D. Ossandón's co-authors include Gad Dotan, Juan Pablo López, Mónica Varas, Gregory H. Reaman, Jaume Català‐Mora, Mariona Suñol, Yaddanapudi Ravindranath, Guillermo Chantada, J. Oscar Croxatto and Claudia Sampor and has published in prestigious journals such as SHILAP Revista de lepidopterología, Pediatric Blood & Cancer and JAMA Ophthalmology.

In The Last Decade

D. Ossandón

18 papers receiving 100 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Ossandón Chile 6 59 47 31 20 18 19 102
Cheryl Fischer United States 7 38 0.6× 32 0.7× 13 0.4× 23 1.1× 7 0.4× 10 113
Nathália Grigorovski Brazil 5 68 1.2× 21 0.4× 17 0.5× 3 0.1× 24 1.3× 7 82
Ronan E. O’Malley United States 10 185 3.1× 127 2.7× 15 0.5× 21 1.1× 20 1.1× 10 238
Jamalia Rahmat Malaysia 5 81 1.4× 54 1.1× 9 0.3× 5 0.3× 23 1.3× 18 106
Isabel Prieto Portugal 6 240 4.1× 195 4.1× 59 1.9× 49 2.5× 20 1.1× 33 304
Felipe Dhawahir-Scala United Kingdom 11 299 5.1× 207 4.4× 12 0.4× 6 0.3× 9 0.5× 35 329
Nenad Vukojević Croatia 7 86 1.5× 91 1.9× 38 1.2× 32 1.6× 7 0.4× 25 163
Raouf Gaber Egypt 10 249 4.2× 226 4.8× 15 0.5× 16 0.8× 17 0.9× 20 309
Robert A. Wiznia United States 9 208 3.5× 128 2.7× 7 0.2× 13 0.7× 12 0.7× 15 248
Nikulaa Parachuri United States 11 306 5.2× 190 4.0× 11 0.4× 10 0.5× 10 0.6× 40 381

Countries citing papers authored by D. Ossandón

Since Specialization
Citations

This map shows the geographic impact of D. Ossandón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Ossandón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Ossandón more than expected).

Fields of papers citing papers by D. Ossandón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Ossandón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Ossandón. The network helps show where D. Ossandón may publish in the future.

Co-authorship network of co-authors of D. Ossandón

This figure shows the co-authorship network connecting the top 25 collaborators of D. Ossandón. A scholar is included among the top collaborators of D. Ossandón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Ossandón. D. Ossandón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sampor, Claudia, Nathália Grigorovski, Alejandro Ceciliano, et al.. (2023). How we approach conservative treatment of retinoblastoma in South America in the era of local ocular treatments: A consensus of the Grupo America Latina de Oncologia Pediatrica (GALOP). Pediatric Blood & Cancer. 70(7). e30352–e30352. 4 indexed citations
2.
Ossandón, D., et al.. (2021). Intra-arterial chemotherapy for retinoblastoma treatment in Chile: Experience and results 2013–2020. Archivos de la Sociedad Española de Oftalmología (English Edition). 96(6). 288–292. 6 indexed citations
3.
López, Juan Pablo, et al.. (2020). Genetic testing for inherited ocular conditions in a developing country. Ophthalmic Genetics. 41(1). 36–40. 6 indexed citations
4.
Ossandón, D., et al.. (2020). Quimioterapia intraarterial para el tratamiento del retinoblastoma en Chile: experiencia y resultados, período 2013-2020. Archivos de la Sociedad Española de Oftalmología. 96(6). 288–292. 5 indexed citations
5.
Ossandón, D., et al.. (2018). A national telemedicine network for retinopathy of prematurity screening. Journal of American Association for Pediatric Ophthalmology and Strabismus. 22(2). 124–127. 20 indexed citations
6.
Sampor, Claudia, Guadalupe Rey, Juan Pablo López, et al.. (2018). Treatment of Nonmetastatic Unilateral Retinoblastoma in Children. JAMA Ophthalmology. 136(7). 747–747. 25 indexed citations
7.
Ossandón, D., et al.. (2017). Resultados anatómicos y refractivos en pacientes tratados por retinopatía del prematuro. Archivos de la Sociedad Española de Oftalmología. 92(10). 472–476. 3 indexed citations
8.
Ossandón, D., et al.. (2017). A national telemedicine network for retinopathy of prematurity screening. Journal of American Association for Pediatric Ophthalmology and Strabismus. 21(4). e20–e20. 1 indexed citations
9.
Ossandón, D., et al.. (2017). Anatomical and refractive outcomes in patients with treated retinopathy of prematurity. Archivos de la Sociedad Española de Oftalmología (English Edition). 92(10). 472–476. 3 indexed citations
10.
Ossandón, D., et al.. (2016). Diagnóstico molecular en pacientes con retinoblastoma: reporte de una serie de casos. Archivos de la Sociedad Española de Oftalmología. 91(8). 379–384. 2 indexed citations
11.
Ossandón, D., et al.. (2016). Molecular diagnosis in patients with retinoblastoma: Report of a series of cases. Archivos de la Sociedad Española de Oftalmología (English Edition). 91(8). 379–384. 2 indexed citations
12.
Ossandón, D., et al.. (2015). Oftalmía Neonatal secundaria a Neisseria Gonorrhoeae: Reporte de un caso clínico y revisión de la literatura.. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Ossandón, D., et al.. (2015). Manejo multidisciplinario en retinoblastoma: experiencia en 37 ojos. Archivos de la Sociedad Española de Oftalmología. 90(2). 55–62. 6 indexed citations
14.
Ossandón, D., et al.. (2015). Telemedicine correlation in retinopathy of prematurity between experts and non-expert observers. Archivos de la Sociedad Española de Oftalmología (English Edition). 90(1). 9–13. 2 indexed citations
15.
Ossandón, D., et al.. (2015). Multidisciplinary management of retinoblastoma: Experience in 37 eyes. Archivos de la Sociedad Española de Oftalmología (English Edition). 90(2). 55–62. 1 indexed citations
16.
Ossandón, D., et al.. (2014). Correlación en telemedicina de retinopatía del prematuro entre observadores expertos y no expertos. Archivos de la Sociedad Española de Oftalmología. 90(1). 9–13. 3 indexed citations
17.
Ossandón, D., et al.. (2014). Using cost-effective intra-arterial chemotherapy to treat retinoblastoma in Chile. Journal of American Association for Pediatric Ophthalmology and Strabismus. 18(6). 617–619. 8 indexed citations
18.
López, Juan Pablo, et al.. (2009). Unilateral eyelid angiofibroma with complete blepharoptosis as the presenting sign of tuberous sclerosis. Journal of American Association for Pediatric Ophthalmology and Strabismus. 13(4). 413–414. 4 indexed citations
19.
Ossandón, D., et al.. (2002). Hernias complicadas: estudio retrospectivos de 369 casos. 43–45.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheryl Fischer Breakdown of academic impact, for papers by Nathália Grigorovski Breakdown of academic impact, for papers by Ronan E. O’Malley Breakdown of academic impact, for papers by Jamalia Rahmat Breakdown of academic impact, for papers by Isabel Prieto Breakdown of academic impact, for papers by Felipe Dhawahir-Scala Breakdown of academic impact, for papers by Nenad Vukojević Breakdown of academic impact, for papers by Raouf Gaber Breakdown of academic impact, for papers by Robert A. Wiznia Breakdown of academic impact, for papers by Nikulaa Parachuri
Rankless by CCL
2026